Clinical Trials · NCT03724409
Selective Intra-arterial Injection of PRRT in Neuroendocrine Tumor Patients With Liver Metastases
- Phase
- EARLY_Phase 1
- Recruitment status
- Terminated
- Sponsor
- Sandeep Laroia
- Enrollment
- 3
- Start date
- Oct 2018
- Locations
- 1 site, United States
- Primary endpoint
- Change in liver enzymes